CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
102 hedge funds and large institutions have $88.7M invested in Cymabay Therapeutics in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 25 closing their positions.
Holders
102
Holders Change
-11
Holders Change %
-9.73%
% of All Funds
2.25%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
16
Increased
29
Reduced
32
Closed
25
Calls
$955K
Puts
–
Net Calls
+$955K
Net Calls Change
+$80K
Top Buyers
1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$4.67M |
2 |
IC
2
Ikarian Capital
Dallas,
Texas
|
$3.5M |
3 |
ECM
3
Engine Capital Management
New York
|
$11.1M |
4 |
VC
4
Vivo Capital
Palo Alto,
California
|
$1.6M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$1.16M |